Table 1.

Comparison of the Omega-3 versus placebo groups with respect to percentage satisfying ACR SLE classification criteria

	All (N = 85) n (%)	Omega-3 (N = 42) n (%)	Placebo (N = 43) n (%)	p value
Malar rash	45 (52.9)	27 (64.3)	18 (41.9)	0.0384
Discoid rash	13 (15.3)	3 (7.1)	10 (23.3)	0.0391
Photosensitivity	51 (60.0)	25 (59.5)	26 (60.5)	0.9294
Oral ulcers	44 (51.8)	22 (52.4)	22 (51.2)	0.9105
Arthritis	68 (80.0)	36 (85.7)	32 (74.4)	0.1930
Serositis	35 (41.2)	12 (28.6)	23 (53.5)	0.0196
Renal disorder	20 (23.5)	13 (31.0)	7 (16.3)	0.1108
Neurologic disorder	6 (7.1)	4 (9.5)	2 (4.7)	0.3805
Hematologic disorder	61 (71.8)	28 (66.7)	33 (76.7)	0.3021
Immunologic disorder	65 (76.5)	31 (73.8)	34 (79.1)	0.5676
ANA positivity	84 (98.8)	42 (100)	42 (97.7)	0.3201